XBiotech (XBIT) EV to CFO (2015 - 2025)

XBiotech has reported EV to CFO for 11 years, with the latest figure at 2.3 in Q4 2025.

• On a quarterly basis, EV to CFO fell 71.27% year-over-year to 2.3 in Q4 2025; TTM through Dec 2025 was 1.32, a 21.79% decrease from a year earlier, with the FY2025 full-year figure at 1.32, down 21.79% from the prior year.
• EV to CFO was 2.3 for Q4 2025 at XBiotech, down from 15.57 in the prior quarter.
• The five-year high for EV to CFO was 151.97 in Q1 2021, with the low at 57.88 in Q4 2021.
• Average EV to CFO over 5 years is 15.87, with a median of 8.24 recorded in 2025.
• The largest YoY upside for EV to CFO was 6566.67% in 2021 against a maximum downside of 206.55% in 2021.
• Over 5 years, EV to CFO stood at 57.88 in 2021, then soared by 160.42% to 34.97 in 2022, then slumped by 34.79% to 22.8 in 2023, then plunged by 64.96% to 7.99 in 2024, then tumbled by 71.27% to 2.3 in 2025.
• The last three EV to CFO figures came in at 2.3 (Q4 2025), 15.57 (Q3 2025), and 10.42 (Q2 2025), per Business Quant data.